95 filings
Page 3 of 5
8-K
wu1e0m2o0aefucw
13 May 20
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
mget1w ho4
23 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:03am
8-K
326a 48kvjg
17 Mar 20
Novus Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results
6:03am
8-K/A
muss83caolh0y74ts
20 Feb 20
Unregistered Sales of Equity Securities
6:12am
8-K
risdoxxezr13c6d0rno
19 Feb 20
Unregistered Sales of Equity Securities
4:11pm
8-K
5o22lkv8w d57
7 Feb 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
4s6 ci9te4bk7fc12p
16 Jan 20
Entry into a Material Definitive Agreement
6:32am
8-K
wnhv2rk59jp
13 Nov 19
Novus Therapeutics Reports Third Quarter 2019 Financial Results
6:00am
8-K
o72udtrk8z
13 Aug 19
Novus Therapeutics Reports Second Quarter 2019 Financial Results
4:37pm
8-K
gmvn36r1oepam2c
9 Aug 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:30pm
8-K
c78urnkkvxofhdxp7xz
12 Jul 19
Changes in Registrant's Certifying Accountant
4:05pm
8-K
0dwn5niy
14 May 19
Novus Therapeutics Reports First Quarter 2019 Financial Results
4:30pm
8-K
sitdbi
2 May 19
Novus Therapeutics Announces $10.7 Million Registered Direct Offering PricedAt-the-Market
4:24pm
8-K
hn6u6sp7c5h 5g
22 Apr 19
Novus Therapeutics Announces Results of Two Single-Dose Phase 1 Studies of OP0201
8:02am
8-K
qgsr2c9
28 Mar 19
Novus Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Clinical Updates
6:04am
8-K
ll7sktj 09hc6mh
8 Jan 19
Regulation FD Disclosure
12:49pm
8-K
jerzn6 de7q5mln
13 Nov 18
Novus Therapeutics Reports Third Quarter 2018 Financial Results
7:58am
8-K
njq2e
7 Aug 18
Novus Therapeutics Reports Second Quarter 2018 Financial Results
8:31am
8-K
fcqmbfqhvw7to
14 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
yu61f x3m9n38ryrsa0
11 May 18
Novus Therapeutics Reports First Quarter 2018 Financial Results
12:00am